02:37 PM, 6th Feb 2026
Orchid Pharma Ltdhas informed BSE that the meeting of the Board of Directors of the Company is scheduled on 11/02/2026 inter alia to consider and approve Unaudited Limited Reviewed Financial Results (Standalone & Consolidated) of the Company for the Quarter-III of Financial Year 2025-26 ended on December 31 2025.